Pharmafile Logo

The Trust Test

- PMLiVE

Reckitt hammered by $1.4bn opioid settlement bill

Case centres on Subaxone marketing practices

- PMLiVE

Another setback on pricing as Trump drops rebate plans

Follows pharma's blocking of advertising changes

- PMLiVE

FDA will maintain the pace, vows Woodcock, but warns of skills gap

Top official unconcerned by dip in approval rate

What does it mean to be an agile organisation

We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market.

Blue Latitude Health

- PMLiVE

FDA verdict on Sanofi’s Darzalex rival is due in April 2020

One of several anti-CD38 antibodies in pipeline

- PMLiVE

Amazon’s Alexa to provide NHS health information

Launched by new NHSX digital change division

- PMLiVE

Alnylam gains key NICE approval for Onpattro

Important milestone for company's first product

Battling breast cancer with precision medicine (Part 2)

Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Blue Latitude Health

Corporate event food. How to get it right

Food affects our mood. When we are hungry, we are more likely to be irritable and unhappy. On the other hand, being full makes us happy and relaxed. But, with...

Apex Events and Exhibitions

How patient insights were brought to life with graphic novel outputs

Research Partnership's client was developing a novel therapy for the treatment of a rare disease in which patients suffer acute symptomatic attacks; the main burden of disease is not just...

Inizio

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links